Cyrano Therapeutics, Inc.

This will be the first major therapy to treat patients who have lost their sense of smell and flavor.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Washington, DC, US
  • Currency USD
  • Employees 3
  • Incorporation Type C-corp
  • Website CyranoTherapeutics.com

Company Summary

Cyrano is developing an intranasal spray to treat the loss of smell and flavor function, a condition that affects 15 million people in the US alone, often caused by a respiratory viral infection or a chronic sinonasal condition.

Team

  • Rick Geoffrion
    President & CEO, Co-Founder

    Highly experienced health care executive and entrepreneur; taste and smell impaired patient.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free